Professor Krishnan Bhaskaran
of Statistical Epidemiology and Sir Henry Dale Fellow
I graduated from Sheffield University with a BSc Hons in Mathematics in 1999 and took an MSc in Medical Statistics at Leicester University in 2000-2001. I worked for 6 years at the MRC Clinical Trials Unit, on a variety of HIV trials and observational studies, with an emphasis on HIV seroconverters (individuals with well estimated dates of HIV infection). In October 2010, on gaining my PhD at LSHTM for a project looking at environmental risk factors for heart disease, I joined the department as a lecturer, and later senior lecturer. I completed an National Institute for Health Research postdoctoral fellowship to study the effects of widely prescribed drugs on cancer risk (2012-2014). I was then awarded a Wellcome Trust/Royal Society Sir Henry Dale Fellowship followed by a Wellcome Senior Research Fellowship to study cardiovascular disease risks among people with a history of cancer (2015 to present).
I am joint Research Degrees Co-ordinator for the Department of Non-Communicable Diseases Epidemiology, and co-director of the Extended Epidemiology MSc module. I deliver several lectures and practical sessions on the MSc in Epidemiology. I teach on the Extended Epidemiology, and Advanced Statistical Methods for Epidemiology (ASME) MSc modules, and on the Advanced Course in Epidemiological Analysis (ACEA) and Practical Pharmacoepidemiology short courses.
My main areas of interest are cancer epidemiology and cancer survivorship, and I lead the Beyond Cancer research group (https://www.lshtm.ac.uk/research/centres-projects-groups/beyond-cancer).
I hold a Wellcome Trust/Royal Society Sir Henry Dale Fellowship for a programme of work looking at cardiovascular diseases among people with a history of cancer. I have also led work on mental health and quality of life among cancer survivors. I will extend these work streams in a Wellcome Senior Research Fellowship beginning in Spring 2021, which will include investigation of broader vascular outcomes, and the role of specific cancer treatments.
I have an ongoing interest in pharmacoepidemiology, particularly in relation to cancer outcomes, and completed an NIHR fellowship programme in this area. I have also studied other predictors of cancer risk, notably body mass index.
Throughout my work I have been interested in the use of eHealth data and am part of a wider group at LSHTM working with large-scale routinely collected data such as the Clinical Practice Research Datalink (CPRD) primary care data. I am one of the statistical leads in the large OpenSAFELY project, an initiative set up at the start of the 2019 COVID-19 pandemic, and designed to use linked health data sources covering most of the population of England to answer key questions about this emerging disease.
Finally, I am interested in methodological questions that arise during research into real clinical problems; for example how best to tackle time-varying confounding by indication in diabetes epidemiology, and when/how to use matching in cohort studies.